Navigation Links
Same molecule found in meat, milk, tumors

A non-human molecule found in red meat and milk makes its way into the human system when eaten -- and seems to build up especially in tumors, say researchers.//

The compound, called sialic acid, is found on the surfaces of animal cells but is not found in people, and may be one reason why animal-to-human organ and tissue transplants do not work well. Animals have a version called Neu5Gc, while humans carry Neu5Ac.

But researchers at have found it does show up in the human body, and showed it can be absorbed from eating red meat and milk.

They also showed that the body produces an immune response against the molecule.

There are already existing recommendations that people should not consume too much food containing saturated fats, such as dairy products and red meats.

The highest amount [of Neu5Gc] was found in lamb, pork, and beef [so-called 'red meat']," said researchers. Levels were very low or undetectable in poultry and fish, vegetables and hen's eggs.

Autoimmune diseases

"The small amounts of Neu5Gc in normal tissues also raise the possibility that anti-Neu5Gc antibodies are involved in autoimmunity," the researchers said.

Autoimmune diseases occur when the body mistakenly attacks healthy tissue and include type-1 or juvenile diabetes and some types of arthritis.

But much research has focused on the fat content of animal fat or byproducts of cooking meat as the cause of disease. Researchers developed an antibody -- an immune system targeting protein -- that would hook onto Neu5Gc. The team found Neu5Gc in human tumor samples and to a much lower degree in healthy tissue.

More tests showed that most people had made their own antibodies that recognized Neu5Gc, and thus could potentially initiate an inflammatory immune response.

“Meat eating has certainly been a feature of human ancestors for many hundreds of thousands of years," th
'"/>




Page: 1 2

Related medicine news :

1. Poisonous Parkinsons molecule discovered
2. Glenmark’s new molecule to go through trial
3. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
4. Ways to counter radiation effects with new molecule discovery
5. New molecule to treat brain disorders found
6. Cell molecules behind neuro degenerative diseases
7. New anti-aging molecule could be coming up in way
8. So now here might come a memory molecule!!!
9. Lost molecule holds the key to lung cancer
10. THC molecule turns out to a boon for Alzheimer’s patient
11. Distraction therapy found very effective in postoperative patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Same molecule found meat milk tumors

(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall/...ny"), a supplier of precision technology products ... annual meeting of the Company,s shareholders has ...me and location of the meeting will be announced i...y received a requisition notice from Stephen Bersh...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 ...ed that Blair Lambert, CFO/COO, will present at th...held at the May Fair Hotel in London, England, on ..., To listen to a live broadcast of The Gymboree ...se log on to www.gymboree.com, click on "Our Compa...
(Date:11/27/2009)... XenaCare Holdings has announced t...tis Foundation, one of the largest nonprofit organ...c health education. , Del...e Holdings, Inc. (OTCBB: XCHO), a company speciali...onsumer healthcare products, has announced today t...
(Date:11/27/2009)... Voyant Health™ announced to...has licensed its TraumaCad Enterprise orthopedic t...ow solution. , (PRWEB) No...today that Spectrum Health (Grand Rapids, Michigan... templating solution and its TraumaCad Extend work...
(Date:11/26/2009)..., NEW YORK, Nov. 27 With cold and... to employ good practices to control the spread of...e proactive not only to keep ourselves healthy, bu...id Eileen Finerty, RN, MS, CIC (certified in infec...rol and occupational health at Hospital for Specia...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...tes 130,000 Jobs and $13.5 Billion in Economic Act... health plans are an essential and vital part of t...3.5 billion in economic activity, according to a...ide consulting firm with expertise in health care ...
...ctos tied to a retinal disorder, study finds , ...s of diabetes drugs called glitazones are associat...complication called diabetic macular edema (DME), ...azone (Actos) and rosiglitazone (Avandia). , The U...
...for valuing the opinions of African American emplo...ent to diversity at Sodexo, a leading integrated f...llows me to be open about who I am as an African A...ervices and chair of the African American Leadersh...
...Missouri, April 7 , - Acquisition Extends the... Elsevier, the leading global publisher of scient...nd services, announced today the acquisition of,th...rated into Elsevier,s Evolve Testing and Remediati...
...eumatology Thought Leader Panel Creates a ,Fantasy... 7 MedPredict Market Research, a global provider ...ket research, has published a new report providing...atic arthritis. , , To develop this analysis, ent...
...L, April 7, 2009) Managing pain in the ICU is an ... care team. However, new reports suggest that taki... be the key to managing pain in the ICU and even d...hysicians (ACCP), the two reports titled, Evaluati...
Other Medicine News:Health News:California Health Plans Vital to State's Economy 2Health News:Certain Diabetes Drugs May Pose Eye Risk 2Health News:Sodexo Named as One of the Top Three Companies for African Americans on 2009 DiversityInc Top Ten Companies List 2Health News:Elsevier Acquires Professional Development Software, Inc., Provider of 'Software for Nurses' Online Learning Education 2Health News:New Report Defines Challenges for New Entrants in Key Rheumatology Markets 2Health News:'Pain in the ICU' report suggests comprehensive approach 2Health News:'Pain in the ICU' report suggests comprehensive approach 3
(Date:11/25/2009)...re/ -- Reportlinker.com announces that a new marke..., Mammography Equipment - A Global Market Per...4330/Mammography-Equipment---A-Global-Market-Persp...er in industrialized as well as developing nations...ammography market. Globally, escalating awareness ...
(Date:11/25/2009)...RNewswire/ -- Cempra Pharmaceuticals Inc. today an...chief executive officer, will present at the Piper...0 a.m. EST, December 1, 2009, at The New York Pala...vide an overview of the company,s two leading anti...-resistant pathogens including MRSA. ,, About ...
(Date:11/25/2009)...Newswire/ -- ChemoCentryx, Inc., announced today...s PROTECT-1 (the Prospective Randomized Oral Thera...t-EN(TM) (CCX282-B) in patients with moderate-to-s...cy with a favorable safety and tolerability profil...ficacy in the reduction of disease severity as def...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media 6219 1Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media 6219 2Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media 6219 3SEA to conduct expedition dedicated to measuring plastic marine debris in the North Atlantic Ocean 10712 1SEA to conduct expedition dedicated to measuring plastic marine debris in the North Atlantic Ocean 10712 2Study Links Yo Yo Dieting to Addiction 61264 1Study Links Yo Yo Dieting to Addiction 61264 2Study Links Yo Yo Dieting to Addiction 61264 3
...E: SHP,Nasdaq: SHPGY), the global specialty biopha...ientific meeting findings from analyses of pivotal...onist. This compound is an,investigational once-da...reatment of the symptoms of Attention Deficit Hype...hat INTUNIV showed significant efficacy in,reducin...
... Expected at ASCO in June -, SOUTH SAN FRANCISCO,...daq: PARD ), a biopharmaceutical company focused,... patient enrollment in,its Phase 2 clinical trial ... the first-line treatment of metastatic colorectal...cted in the second half of 2008. Picoplatin,the Co...
Other Medicine Technology:Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4
HbA1c/Hb Calibrator Series
STA HEPANORM H
STA HEPARIN CONTROL
STA COAG CONTROL N + ABN
Medicine Products: